Yee Peng Phoon

3PUBLICATIONS
36CO-AUTHORS
Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8<sup>+</sup> T cell responses.

Hieu Minh Ta, Dia Roy, Keman Zhang

|Apr 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics.

Yee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel

|Nov 22, 2021
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.

Chuan Li, Yee Peng Phoon, Keaton Karlinsey

Pageof 1

Frequent Collaborators

2 joint publications

Brian R Gastman

2 joint publications

Pauline Funchain

1 joint publications

Chuan Li

1 joint publications

Keaton Karlinsey

1 joint publications

Ye F Tian

1 joint publications

Samjhana Thapaliya

1 joint publications

Angkana Thongkum

1 joint publications

Lili Qu

1 joint publications

Alyssa Joyce Matz

1 joint publications

Mark Cameron

Frequent Collaborators

2 joint publications

Brian R Gastman

2 joint publications

Pauline Funchain

1 joint publications

Chuan Li

1 joint publications

Keaton Karlinsey

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.2K
See more related videos

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.2K
See more related videos